OpGen's products and services provide rapid molecular diagnostic solutions that help guide clinicians with actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of multidrug-resistant microorganisms (MDROs). The company's mission is to harness the power of molecular microbiology and bioinformatics to develop diagnostic solutions that optimize the treatment of life-threatening, drug-resistant infections.